Obesity: A Holistic Approach in Integrative Care

Obesity integrative care provides a holistic approach to managing weight and enhancing quality of life. Learn more today.

Abstract

As a clinician dedicated to integrative and functional medicine, I continually explore the intricate connections among various health conditions. In this comprehensive educational post, I, Dr. Alex Jimenez, will guide you through the complex interplay between obesity, reproductive health, psychiatric well-being, sleep, and metabolic function in adults. We will examine conditions like Polycystic Ovary Syndrome (PCOS), gestational hypertension, and preeclampsia, and discuss their profound impact on maternal and child health, extending even to future generations through epigenetic mechanisms. Drawing on current research, I will explain the physiological mechanisms behind stress-induced inflammation, insulin resistance, and appetite dysregulation. This post will detail evidence-based strategies for diagnosis and management, focusing on lifestyle interventions, nutritional guidance, and the judicious use of modern pharmacotherapy, such as metformin and GLP-1 agonists. Throughout, I will highlight how our multidisciplinary team at Injury Medical Clinic PA, featuring the collaborative expertise of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, integrates chiropractic care, functional medicine, and conventional medical oversight to provide comprehensive, patient-centered treatment plans that address these multifaceted health challenges. We will also explore this approach through detailed case studies that illustrate our stepwise process from diagnosis to successful, long-term health outcomes.

Our Multidisciplinary and Collaborative Care Model In El Paso, Texas

Hello, I’m Dr. Alex Jimenez. With my credentials as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), Board-Certified Family Nurse Practitioner (FNP-BC), and advanced certifications in functional medicine (CFMP, IFMCP, ATN, CCST), I have dedicated my career to understanding the body as an interconnected system.

At our practice, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we champion a multidisciplinary model of care. Our practice is built on a foundation of collaboration, most notably with our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a highly respected, Board-Certified Internist with over 40 years of invaluable clinical experience (NPI #1164426749, Texas MD License #J2933). She provides essential medical oversight for our patients, creating a truly integrative environment where different disciplines work in synergy.

This shared framework is common and effective in settings like ours, which focus on injury care and complex chronic conditions. Together, our team integrates:

• Medical Direction (Dr. Cardenas): Provides essential oversight, prescription management, risk stratification, and diagnosis from an internal medicine perspective, ensuring medical safety in complex cases.
• Chiropractic & Functional Medicine (Dr. Jimenez): I focus on neuromusculoskeletal alignment, pain modulation, autonomic balance, biomechanics, and addressing the root causes of disease through a functional medicine framework.
• Comprehensive Services: We also offer personal injury care, advanced rehabilitation, nutritional counseling, medically supervised weight management, and other supportive therapies.

This collaborative structure allows us to blend the best of chiropractic care, functional medicine, rehabilitation, and traditional internal medicine to create truly holistic and effective treatment pathways for our community. Today, I want to share insights from leading researchers in obesity medicine, framing their findings through my lens as an integrative practitioner. We will journey through some of the most critical health considerations for adults living with obesity, starting with reproductive health and expanding into metabolic and psychiatric wellness.

Navigating Polycystic Ovary Syndrome (PCOS) in Integrative Care

Polycystic Ovary Syndrome, or PCOS, is far more than just a reproductive issue; it’s the most common endocrine disorder affecting women of reproductive age and a condition I frequently encounter in my practice. It impacts about 10% of women and carries a strong genetic component, with a higher prevalence among women of Spanish, Native American, and Mexican descent. I see this firsthand in our El Paso community. It’s crucial to understand PCOS not as an isolated event but as a chronic disease that influences a woman’s neuroendocrine, metabolic, and reproductive health throughout her entire life.

While its symptoms often manifest in premenopausal women, the underlying cardiometabolic consequences persist long after. The connection between PCOS and obesity is undeniable; an estimated 60-80% of women with PCOS also have obesity. In my practice, I prefer the term “early obesity” over “overweight,” as it more accurately frames the condition as part of a progressive disease spectrum that requires early and proactive intervention.

The clinical picture of PCOS is often characterized by:

• Menstrual irregularities: This can range from infrequent periods (oligomenorrhea) to a complete absence of periods (amenorrhea).
• Hyperandrogenism: This is an excess of androgens (male hormones), which can manifest physically as acne, unwanted hair growth (hirsutism), or male-pattern hair loss. Lab tests can also confirm elevated androgen levels.
• Excess ovarian activity: Ultrasounds often reveal multiple small follicles on the ovaries, giving them a “polycystic” appearance.
• Chronic low-grade inflammation: This systemic inflammation contributes to many of the long-term health risks associated with PCOS.
• Insulin Resistance and Obesity: These are central pillars of the syndrome.

The Central Role of Insulin Resistance

To truly grasp PCOS, we must understand insulin resistance. Imagine three overlapping circles in a Venn diagram: obesity, insulin resistance, and PCOS. They are deeply intertwined. Although insulin resistance is not officially part of the diagnostic criteria, from a functional medicine perspective, it is the pathogenic driver behind the syndrome’s progression.

Here’s how it works physiologically:

1. Insulin Resistance Develops: The body’s cells become less responsive to insulin, the hormone that helps shuttle glucose from the bloodstream into cells for energy.
2. Hyperinsulinemia Occurs: To compensate, the pancreas pumps out increasing amounts of insulin. This state of high insulin is called hyperinsulinemia.
3. Ovarian Androgen Production is Stimulated: High insulin levels directly stimulate the ovaries to produce excess androgens. This disrupts the delicate hormonal balance needed for regular ovulation.
4. Metabolic Chaos Ensues: This hormonal cascade also contributes to dyslipidemia (abnormal blood fats), increases the risk for type 2 diabetes and cardiovascular disease, promotes non-alcoholic fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease or MASLD), and perpetuates a state of chronic inflammation that makes weight gain easier and weight loss harder.

The complications stemming from this are serious and can profoundly impact a woman’s health, both now and in the future. These include infertility, higher rates of gestational diabetes, preeclampsia, miscarriage, endometrial cancer, metabolic syndrome, obstructive sleep apnea, hypertension, heart disease, depression, anxiety, and eating disorders. The emotional toll is immense, affecting a woman’s self-esteem and quality of life.

Diagnosing PCOS in a Clinical Setting

In my practice, we use the widely accepted Rotterdam 2003 consensus criteria for diagnosis. A woman is diagnosed with PCOS if she meets at least two of the following three criteria, after other potential causes have been ruled out:

• Hyperandrogenism: Confirmed either by clinical signs (acne, hirsutism) or lab work showing elevated androgen levels.
• Ovulatory Dysfunction: A history of irregular or absent menstrual cycles.
• Polycystic Ovaries on Ultrasound: The presence of 12 or more follicles on an ovary or increased ovarian volume.

Often, I can make a confident diagnosis based on the first two criteria alone, without the need for an immediate ultrasound, allowing us to begin treatment promptly (Legro et al., 2013).

An Integrative and Functional Approach to Managing PCOS

At our clinic, we believe in a “root cause” approach. Since obesity and insulin resistance are at the heart of PCOS, our primary strategy is to treat obesity first. Even a modest weight reduction of just 5-7% can have a dramatic impact, often restoring the menstrual cycle and spontaneous ovulation. This is a critical point of counseling: as we begin treatment, fertility can return quickly, so conversations about contraception are essential if pregnancy is not immediately desired (Moran et al., 2011).

Our goal is to reduce adiposity (excess body fat) and improve metabolic function through a multifaceted plan.

Foundational Pillar 1: Therapeutic Nutrition

Since insulin resistance is essentially a state of carbohydrate intolerance, our nutritional guidance centers on managing insulin levels.

• Reduce Ultra-Processed Foods: We guide patients to significantly limit starches, sweets, refined grains, and alcohol. These foods cause sharp spikes in blood sugar and insulin, which worsen androgen production and fat storage.
• Prioritize Protein and Fiber: A diet rich in high-quality protein (which includes healthy fats) and fiber from vegetables and low-glycemic fruits helps promote satiety, stabilize blood sugar, and reduce insulin surges.
• Meal Timing and Size: We often recommend smaller, more frequent meals over large, infrequent ones. Even when eating low-carb, a very large meal can trigger a significant release of insulin. This is because insulin is a primary fat-storage hormone; when its levels are high, the body is signaled to store fat and is blocked from burning it for energy.

Foundational Pillar 2: Strategic Physical Activity

When it comes to PCOS, exercise is not just about “burning calories.” It is a powerful tool for improving glucose and insulin metabolism.

• Short, Frequent Sessions: Research shows that multiple short activity sessions (e.g., three 10-minute walks) spread throughout the day can be more effective at improving insulin sensitivity than a single continuous 30-minute session. This is an empowering message for patients who feel overwhelmed by the idea of long workouts.
• Daily Cardio Activity: We encourage daily cardiovascular exercise, aiming for 2-3 10-20-minute sessions. Of course, any activity is better than none, so if a single 30-minute walk is what a patient can realistically do, we celebrate and support that.
• Resistance Training: Incorporating 1-2 resistance training sessions per week is crucial. Building lean muscle mass increases the body’s “glucose sinks”—more muscle means more places for glucose to go, which directly improves insulin sensitivity and boosts metabolic rate.

Foundational Pillar 3: Chiropractic and Medical Support

This is where our integrated model truly shines.

• Chiropractic Care: As a chiropractor, I focus on the neuro-musculoskeletal system. Chronic stress, a common companion to PCOS, can lead to hypothalamic-pituitary-adrenal (HPA) axis dysfunction, further disrupting hormonal balance. Chiropractic adjustments can help modulate the nervous system, reduce physiological stress responses, and improve overall well-being. Furthermore, we help patients overcome the musculoskeletal pain that may be a barrier to starting a new physical activity program, ensuring they can move with confidence and without injury.
• Pharmacological Intervention: For many women with PCOS and evident insulin resistance, I prescribe Metformin (off-label). It is a well-established medication that helps lower glucose production in the liver and improve insulin sensitivity in the peripheral tissues (Naderpoor et al., 2015). I typically start with a 500 mg extended-release formula and titrate the dose up slowly to maximize tolerability.
• Advanced Obesity Medications: When choosing an anti-obesity medication, drugs in the GLP-1 receptor agonist class (like semaglutide or liraglutide) are often the optimal choice for patients with PCOS. They not only promote weight loss but also have direct benefits on insulin sensitivity and glucose control. However, all FDA-approved obesity medications can be effective tools for reducing adiposity.
• Hormonal Management: Under the medical direction of Dr. Cardenas, we also address other hormonal aspects. For women with irregular menses, we may prescribe combined oral contraceptives to provide endometrial protection and regulate cycles. For distressing symptoms such as acne or hirsutism, a medication like Spironolactone can be very effective in blocking androgen effects on the skin and hair follicles (Azziz, 2018).

The Profound Impact of Maternal Weight on Pregnancy Outcomes

As a clinician, I frequently encounter patients whose health goals are tied to starting or expanding their families. A critical, yet often sensitive, topic in this conversation is maternal weight and metabolic health. The latest research from leading experts underscores a clear and significant connection between a mother’s health status before and during pregnancy and the outcomes for both her and her baby.

When a mother enters pregnancy with excess weight or develops conditions like gestational hypertension and preeclampsia, the risks escalate dramatically. From a physiological standpoint, pregnancy naturally induces a state of mild insulin resistance to ensure the growing fetus has an adequate supply of glucose. However, in a woman who already has obesity and underlying insulin resistance, this effect is amplified (Catalano & Shankar, 2017). These conditions are not just minor complications; they are serious medical issues that can lead to:

• Adverse Fetal Outcomes: A higher likelihood of miscarriage, fetal demise, preterm birth, and even congenital disabilities.
• Maternal Health Risks: Increased risk of thromboembolism (blood clots), a higher probability of requiring a Cesarean section, and a greater chance of postpartum complications such as infection, hemorrhage, and poor wound healing.
• Mental Health Challenges: Elevated rates of peripartum and postpartum depression, which can profoundly affect the mother-infant bond and overall family well-being.

It is heartbreaking that many of these women experience discrimination and humiliation from healthcare professionals during what should be a supported and positive time in their lives. Our role as healthcare providers is to offer proactive, evidence-based, and, above all, compassionate care.

The Generational Echo: Epigenetics and Obesity

The influence of parental health extends far beyond a single pregnancy. We are now beginning to fully appreciate the epigenetic impact—how environmental factors and behaviors can change the way our genes work without altering the DNA sequence itself. Elevated circulating fats (lipids) in the mother can cross the placenta. This “in-utero programming” can affect the fetus’s metabolic development, increasing their risk for obesity and metabolic disease later in their own childhood and adulthood (Poston et al., 2021).

Here’s what the evidence tells us (Hanson & Gluckman, 2014):

• Parental Adiposity: It’s crucial to note that this is not just about the mother. Maternal and paternal adiposity (excess body fat) significantly increases the offspring’s risk of becoming overweight or obese.
• Long-Term Disease Risk: This inherited risk factor also predisposes the child to a future of chronic diseases, including cardiovascular disease, type 2 diabetes, and certain cancers.
• The Cycle of Obesity: When a mother has unmanaged gestational diabetes or poor nutrition during pregnancy, her child is born with an increased propensity for obesity and metabolic dysfunction. This child then grows into an adult who may face the same challenges, perpetuating a generational cycle of obesity.

This is why this topic is so profoundly important. My goal as a functional medicine practitioner is to empower women to break this cycle. By improving a woman’s weight and metabolic health before she even conceives, we can make a substantial, positive impact on the health of generations to come.

Preconception Counseling: A Crucial First Step

One of the most powerful tools we have is preconception counseling. The idea is to counsel women to achieve a healthier weight before attempting pregnancy. This can sometimes be a challenging conversation, but when we frame it around the immense benefits, it becomes a compelling and motivating goal.

We explain that preconception weight reduction isn’t just about making conception easier; it’s about safeguarding their health during pregnancy and, most importantly, giving their future child the best possible start in life. The research is overwhelmingly supportive. When we intervene with lifestyle changes, we can help women reduce maternal weight gain by 3 to 9 kilograms (about 7 to 20 pounds). When we combine lifestyle with appropriate medications, like metformin or an obesity medication, that reduction can be even more significant (Poston et al., 2015).

The benefits are profound and measurable:

• Improved Metabolic Markers: We observe significant reductions in fasting insulin and glucose levels.
• Reduced Insulin Resistance: The body becomes more sensitive to insulin, which is a cornerstone of metabolic health.
• Lowered Gestational Diabetes Risk: A staggering 20% to 30% decrease in the rate of developing gestational diabetes.
• Healthier Baby Size: A 20% to 40% decrease in macrosomia (a condition where a baby is born significantly larger than average), which reduces birth complications (American College of Obstetricians and Gynecologists, 2021).

Treatment Modalities for Preconception Weight Management

We use a multi-pronged, integrative approach to achieve these results.

1. Lifestyle Interventions: This is always our first step.

• • Healthful Nutrition: I recommend the same nutritional guidelines used for reversing insulin resistance—a focus on whole foods, adequate protein, and high fiber, while minimizing processed foods and sugars.
  • Physical Activity: Regular movement is non-negotiable.
  • Sleep and Stress Management: These are foundational pillars of health that directly impact hormones and metabolism. Integrative chiropractic care plays a vital role here. By addressing spinal misalignments and reducing nervous system interference through adjustments, we can help lower the body’s stress response (cortisol levels) and improve sleep quality, creating a more favorable physiological environment for weight loss and hormonal balance.

• Obesity Medications: For many, lifestyle changes alone are not enough to overcome significant metabolic dysfunction. In these cases, medications can be a powerful bridge to better health.

• • GLP-1 Agonists (e.g., Semaglutide, Tirzepatide): These medications have been revolutionary in helping patients achieve substantial weight loss. It is critical, however, to plan for pregnancy. The labels for these medications recommend a 2-month washout period before conception for both women and men to ensure the drugs are completely cleared from the body (Liraglutide and Semaglutide Prescribing Information, 2023; Tirzepatide Prescribing Information, 2023).
  • Metformin: This is a highly effective medication, especially for women with pronounced insulin resistance or PCOS. It can often be safely continued into pregnancy under the guidance of the obstetrician (Metformin in pregnancy for women with polycystic ovary syndrome (PCOS), 2019).

• Post-Bariatric Surgery: For women who have undergone bariatric surgery, it’s recommended to wait at least two years post-surgery before attempting pregnancy to ensure nutritional stability and allow the body to heal.

The Importance of Breastfeeding: Benefits and Barriers

Once the baby arrives, breastfeeding offers a wealth of benefits for both mother and child.

For the Mother:

• Lower lifetime risk of breast and ovarian cancer.
• Reduced risk of developing type 2 diabetes.
• Improved cardiovascular health, with lower rates of heart disease, stroke, and death from cardiovascular events.

For the Baby:

• Enhanced immunity and protection from infections.
• Reduced lifetime cardiovascular risk.
• Lower risk of obesity in both childhood and adulthood (Victora et al., 2016).

Despite these clear benefits, women with obesity face numerous physical and psychological barriers to breastfeeding. They have lower initiation rates and tend to breastfeed for shorter durations. These barriers include difficult labor, higher rates of C-sections, inadequate milk supply (or the perception of it), difficulties with positioning, and the psychological toll of weight stigmatization. Our role is to proactively address these barriers before delivery, connecting patients with lactation specialists and support groups.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

Stress, Sleep, and Mental Health: The Other Side of the Weight Equation

Obesity is a complex, chronic disease shaped by interlocking systems that go far beyond diet and exercise. Our integrative approach also deeply considers how chronic stress, psychiatric conditions, sleep disorders, and eating behaviors converge to influence metabolic health and weight.

Stress, Inflammation, and Metabolism: Why the Body Gains and Guards Weight

Chronic stress is not just a feeling—it is a full-body signal cascade. Under persistent stress, the hypothalamic-pituitary-adrenal (HPA) axis increases cortisol, while sympathetic activity rises and vagal tone falls. The net result is a pro-inflammatory milieu that reshapes metabolism and behavior.

• Key physiological drivers:

• • Elevated cortisol levels increase hepatic gluconeogenesis and impair insulin receptor signaling, contributing to insulin resistance and a higher fasting glucose baseline (Black, 2006).
  • Low-grade systemic inflammation raises cytokines such as IL-6 and TNF-α, which worsen insulin signaling at the cellular level and promote adipocyte hypertrophy (Hotamisligil, 2006).
  • Autonomic imbalance favors sympathetic dominance, paradoxically promoting central adiposity over time through stress-eating and sleep disruption (Thayer & Lane, 2007).

As stress accumulates, the background inflammation “simmers” and then spills into metabolic dysfunction such as insulin resistance and prediabetes. This becomes a vicious cycle—higher insulin drives hunger and fat storage, while fatigue reduces activity, compounding weight gain.

Integrating Chiropractic Care: Pain is a potent driver of the sympathetic response. By restoring joint mechanics, reducing myofascial nociception, and improving thoracic mobility, we modulate afferent input to the central nervous system. This can improve autonomic balance, reduce pain-related sleep fragmentation, and attenuate HPA activation, thereby reducing stress-related eating patterns. In functional medicine terms, improving “input signals” to the nervous system often improves “output” in appetite control and sleep stability.

Psychiatric Conditions and Weight Health: A Two-Way Street

Psychiatric conditions—anxiety, depression, PTSD, bipolar disorder, OCD, and ADHD—intersect closely with weight health. Some medications are weight-promoting; untreated conditions often lead to poor sleep, irregular eating, and increased cravings. In our practice, we use validated screening tools like the PHQ-9 for depression and GAD-7 for anxiety to identify these connections early (Kroenke et al., 2001; Spitzer et al., 2006).

Under the oversight of Dr. Cardenas, we review whether medications are weight-inducing (e.g., certain SSRIs, mirtazapine) and coordinate with mental health professionals to consider alternatives. For untreated conditions, we discuss evidence-based options, such as bupropion/naltrexone, that may support both mood and weight (Apovian et al., 2013). For patients on psychiatric medications that cause weight gain, off-label metformin can be a valuable tool to mitigate these side effects (De Silva et al., 2016).

Eating Disorders and Disordered Eating: Recognize, Screen, and Refer

Eating disorders are complex mental health conditions that require careful screening and management. They have the second-highest mortality rate of all psychiatric illnesses and can be precipitated or worsened by weight loss interventions if behavioral supports are lacking (Hay et al., 2017).

We use screening tools like the SCOFF questionnaire and ESP to identify at-risk individuals (Morgan et al., 1999; Cotton et al., 2003). Our management involves early referral to specialists and pairing any anti-obesity medications with robust behavioral therapy. Different medications can target specific eating behaviors:

• Constant thoughts about food: Bupropion/naltrexone can help regulate cravings.
• Inability to control hunger: Phentermine/topiramate can be effective.
• Loss of control and intense cravings: GLP-1 agonists such as semaglutide and tirzepatide can modulate appetite and reward pathways (Wilding et al., 2021; Jastreboff et al., 2022).

Sleep and Weight Health: The Hormonal Crossroads

Healthy sleep (7–9 hours) is one of the most potent non-pharmacologic tools for metabolic health. Sleep restriction increases ghrelin (the hunger hormone) and decreases leptin (the satiety hormone), driving overeating and altering reward processing for hyperpalatable foods (Taheri et al., 2004).

Obstructive Sleep Apnea (OSA) is a major metabolic brake. It arises when the upper airway collapses during sleep, causing intermittent oxygen drops and arousals. Untreated OSA is strongly linked to hypertension, dysglycemia, and weight gain (Punjabi, 2008). We screen all patients with obesity for OSA and integrate treatment, which may include PAP therapy and weight reduction. Notably, tirzepatide was recently FDA-approved for adults with obesity and moderate-to-severe OSA, having been shown to reduce the apnea-hypopnea index and body weight significantly (Goodman et al., 2024).

Case Journeys: Our Integrative Approach in Action

To put all of this into a real-world context, I want to share the stories of two patients, “Natasha” and “Alex,” whose journeys illustrate the power of our integrative model. Names and some details have been changed to protect patient privacy.

A Case Study: Natasha’s Journey to a Healthy Pregnancy

Natasha, a 33-year-old, came to us wanting to prepare for a second pregnancy. Her history was complex: weight gain since puberty, difficulty conceiving her first child, and a history of preeclampsia requiring an emergency C-section. Her BMI was 40.9 (Class III Obesity), her blood pressure was elevated despite medication, and her labs revealed severe metabolic dysfunction, including prediabetes (A1C 6.1%) and very high fasting insulin (22.1).

Our Stepwise Treatment Plan:

Our goal was to help Natasha lose weight over 1 to 2 years.

1. Nutrition: A reduced-carbohydrate plan focusing on 90-100 grams of protein and ample fiber from vegetables.
2. Physical Activity: We started small with 10-minute walks and gradually introduced resistance training.
3. Medication: Under Dr. Cardenas’s medical supervision, we initiated Metformin ER for insulin resistance and later added Tirzepatide to accelerate weight loss.
4. Chiropractic Care: Regular adjustments helped manage the physical stress on her body and improved her nervous system function, supporting her body’s ability to heal and regulate itself.

Two Years Later: A Remarkable Transformation

Natasha’s BMI dropped to 28.8. Her blood pressure, lipids, and liver enzymes all normalized. Her A1C was 5.5%, and her fasting insulin improved dramatically to 7.9.

Preparing for Pregnancy:

We discontinued the Tirzepatide for the recommended two-month washout period, using a temporary bridge medication to prevent rebound weight gain. Four months after stopping all contraindicated medications, Natasha became pregnant. Her OB approved her to continue her eating plan, physical activity, and metformin.

The Outcome: Natasha had an uneventful pregnancy and is now successfully breastfeeding her healthy baby. Her story is a powerful example of what is possible with a dedicated, patient-centered, and integrative approach.

A Case Journey: Alex — PCOS, Mood Stability, and Sustainable Weight Health

I met Alex intending to create one effective, sustainable strategy for her weight health. She presented with PCOS, insulin resistance, vitamin D deficiency, binge eating disorder, depression, and anxiety. Her psychiatrist had her on paroxetine, an SSRI associated with weight gain.

Our Integrative Plan:

• Pharmacotherapy: Under Dr. Cardenas’s direction, we initiated Metformin for PCOS and insulin resistance. We coordinated with Alex’s psychiatrist to switch her antidepressant to sertraline, which has a more neutral weight profile. Later, we added semaglutide (a GLP-1 RA) to target appetite, cravings, and central satiety signaling. We also corrected her vitamin D deficiency.
• Nutrition and Activity: We started with ten minutes of enjoyable daily movement and implemented a low-carbohydrate, protein-forward nutrition plan.
• Chiropractic and Rehabilitation: We addressed kinetic chain imbalances in her lumbopelvic region and thoracic spine to make daily activity more comfortable and efficient. We also worked on breathing mechanics to downregulate sympathetic tone and reduce stress-related cravings.

Outcomes at Six Months:

Alex achieved a 15% reduction in total body weight. Her waist circumference decreased, reflecting improved visceral adiposity, and her lab markers for cholesterol, insulin, and glucose all normalized or significantly improved. The reinforcing loop was clear: improved movement from chiropractic care enabled better exercise adherence, which improved her insulin sensitivity and mood, further supporting her dietary consistency.

From my clinical practice, I’ve observed that patients with chronic neck and mid-thoracic dysfunction often report lighter, more continuous sleep after restoring rib and diaphragmatic mechanics—and their cravings tend to fall as sleep stabilizes. These real-world results, which I often discuss on my platforms like PushAsRx and LinkedIn, highlight how a truly integrated approach creates synergy that goes beyond what any single therapy can achieve.

Conclusion: Evidence-Based, Human-Centered Care

When patients ask for a single, effective strategy for their weight and health, our job is to integrate—safely and thoughtfully. With Dr. Maria Guadalupe Cardenas, MD, guiding medical oversight and our chiropractic-functional medicine approach to nutrition and behavior, we deliver care that respects both physiology and human experience. Our approach harnesses modern pharmacotherapy, rigorous monitoring, hands-on rehabilitation, and collaborative behavioral health, enabling real improvements in weight, biomarkers, mood, and quality of life.

This integrated path transforms brief successes into durable patterns. Obesity care is a marathon, and the most reliable strategy is a coordinated plan that meets patients where they are while steadily improving their metabolic, mental, and musculoskeletal health. If you are navigating these complex health challenges, consider a multidisciplinary plan. The synergy between internal medicine, Nutritionic, functional nutrition, and behavior support can make all the difference.

References

• American College of Obstetricians and Gynecologists. (2021). Obesity in pregnancy. ACOG Practice Bulletin No. 230. Obstetrics & Gynecology, 137(6), e128-e144.
• American Heart Association. (2018). Eating disorders and cardiovascular health.
• American Psychiatric Association. (2020). Practice guideline for the treatment of patients with eating disorders.
• American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR).
• Apovian, C. M., Aronne, L., Rubino, D., Still, C., Wyatt, H., Burns, C., Kim, D., Dunayevich, E., & COR-II Study Group. (2013). A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity, 21(5), 935–943.
• Azziz, R. (2018). Polycystic Ovary Syndrome. Obstetrics and Gynecology, 132(2), 321–336.
• Black, P. H. (2006). The inflammatory consequences of psychologic stress. Brain, Behavior, and Immunity, 20(2), 119–126.
• Catalano, P. M., & Shankar, K. (2017). Obesity and pregnancy: mechanisms of short-term and long-term adverse consequences for mother and child. BMJ, 356, j1.
• Childs, J. D., et al. (2004). Physical therapy and spinal manipulation for low back pain. Journal of Orthopaedic & Sports Physical Therapy, 34(8), 409.
• Cotton, M. A., Ball, C., & Robinson, P. (2003). Four simple questions can help screen for eating disorders. Journal of General Internal Medicine, 18(1), 53–56.
• Czeisler, C. A., Walsh, J. K., Wesnes, K. A., Arora, S., Roth, T., … Dinges, D. F. (2005). Modafinil for excessive sleepiness associated with shift-work sleep disorder. The New England Journal of Medicine, 353(5), 476–486.
• da Silva, T. (2017). Mechanisms of spinal manipulation. Chiropractic & Manual Therapies, 25, 30.
• Davies, M. J., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989-1002.
• De Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., Hanwella, R. (2016). Metformin in prevention and treatment of antipsychotic induced weight gain: A systematic review and meta-analysis. BMC Psychiatry, 16, 341.
• Gadde, K. M., et al. (2011). Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial. The Lancet, 377(9774), 1341-1352.
• Goodman, B. N., et al. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. The New England Journal of Medicine, 391.
• Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomized, double-masked, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605.
• Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation, 139(25), e1082-e1143.
• Hall, K. D., et al. (2019). Ultra-processed diets cause excess calorie intake and weight gain: An inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism, 30(1), 67-77.e3.
• Hanson, M., & Gluckman, P. (2014). Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiological Reviews, 94(4), 1027–1076.
• Hawley, J. A., et al. (2014). Nutritional modulation of training-induced skeletal muscle adaptations. Journal of Applied Physiology, 117(6), 535- 545.
• Hay, P., Mitchison, D., Collado, A. E. L., et al. (2017). Burden and health-related quality of life of eating disorders, including unexplored areas: A review. Journal of Eating Disorders, 5, 23.
• Hirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873–1875.
• Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860- 867.
• Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216.
• Jensterle, M., et al. (2015). Short-term treatment with liraglutide in morbidly obese women with polycystic ovary syndrome and hirsutism. Archives of Gynecology and Obstetrics, 292(2), 441-449.
• Kessler, R. C., Adler, L., Ames, M., et al. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256.
• Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
• Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565–4592.
• Liraglutide and Semaglutide Prescribing Information. (2023). Novo Nordisk Inc.
• McElroy, S. L., et al. (2007). Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. The American Journal of Psychiatry, 164(1), 145-152.
• McElroy, S. L., et al. (2016). Lisdexamfetamine dimesylate for binge eating disorder in adults: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 164(7), 453-461.
• Metformin in pregnancy for women with polycystic ovary syndrome (PCOS). (2019). Cochrane Database of Systematic Reviews.
• Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011). Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, (7), CD007506.
• Morgan, J. F., Reid, F., & Lacey, J. H. (1999). The SCOFF questionnaire: A new screening tool for eating disorders. BMJ, 319(7223), 1467–1468.
• Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015). Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Human Reproduction Update, 21(5), 560–574.
• National Eating Disorders Association. (2022). Statistics & research on eating disorders.
• Pittas, A. G., et al. (2010). Vitamin D and cardiometabolic outcomes: a systematic review. Annals of Internal Medicine, 152(5), 307-314.
• Poston, L., Bell, R., Croker, H., Flynn, A. C., Godfrey, K. M., & Goff, L. (2015). Effect of a behavioral intervention in obese pregnant women (the UPBEAT study): a multicentre, randomized controlled trial. The Lancet Diabetes & Endocrinology, 3(10), 767-777.
• Poston, L., Calomarde-Perales, M. J., & Hanson, M. (2021). The importance of maternal obesity as a risk factor for adolescent obesity. Nature Reviews Endocrinology, 17(10), 625–639.
• Punjabi, N. M. (2008). The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 5(2), 136–143.
• Serretti, A., & Mandelli, L. (2010). Antidepressants and body weight: a comprehensive review and meta-analysis. Journal of Clinical Psychiatry, 71(10), 1259-1272.
• Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
• St-Onge, M. P., Mikic, A., & Pietrolungo, C. E. (2016). Effects of diet on sleep quality. Advances in Nutrition, 7(5), 938–949.
• Taheri, S., Lin, L., Austin, D., Young, T., & Mignot, E. (2004). Short sleep duration is associated with lower leptin, higher ghrelin, and higher BMI. PLoS Medicine, 1(3), e62.
• Thayer, J. F., & Lane, R. D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224–242.
• Tirzepatide Prescribing Information. (2023). Eli Lilly and Company.
• Victora, C. G., Bahl, R., Barros, A. J., França, G. V., Horton, S., Krasevec, J., … & Rollins, N. C. (2016). Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. The Lancet, 387(10017), 475-490.
• Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002.
• Wright, K. P., Jr., Bogan, R. K., & Wyatt, J. K. (2013). Shift work and the assessment and management of shift work disorder. Sleep Medicine Reviews, 17(1), 41–54.
• Zang, M., et al. (2004). Metformin and phenformin activate AMP-activated protein kinase and inhibit acetyl-CoA carboxylase activity in cultured human hepatoma cells and rat skeletal muscle. Diabetes, 53(12), 3125-3132.

SEO Tags: integrative chiropractic care, obesity treatment, PCOS, Polycystic Ovary Syndrome, Insulin Resistance, Integrative Medicine, Functional Medicine, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Reproductive Health, Pregnancy and Obesity, preconception health, maternal obesity, gestational diabetes, preeclampsia, metabolic health, pregnancy wellness, postpartum care, GLP-1, metformin, semaglutide, tirzepatide, topiramate, phentermine, bupropion naltrexone, vitamin D deficiency, hyperlipidemia, internal medicine collaborative care, El Paso Injury Medical Clinic, Mission Plaza Injury Medical Clinic, medical director Dr Maria Guadalupe Cardenas, Dr Alex Jimenez DC APRN FNP-BC, functional medicine nutrition, rehabilitation for obesity, bariatric surgery discussion, cardiology clearance phentermine, cravings and hunger management, musculoskeletal pain and obesity, stress inflammation weight gain, sleep apnea obesity, binge eating disorder management, ADHD obesity medications, PHQ-9 GAD-7 screening, SCOFF ESP eating disorder screening, shift work disorder sleep, autonomic balance chiropractic, diaphragmatic breathing weight loss, women’s health, hormonal imbalance, chronic disease management, case study, collaborative care, injury medical clinic, epigenetics, generational health